Novo Nordisk, the Danish developer of Ozempic, announced Wednesday a partnership with Anthropic to use Anthropic's Claude model to advance drug discovery research and development and aid its own softw…
A University of Pennsylvania School of Engineering and Applied Science team analyzed more than 400,000 Reddit posts from nearly 70,000 users over five years and identified reproductive symptoms, inclu…
Noom, the weight-loss and wellness company founded in 2008, is offering multiple promo codes and free trials for August 2026, including $20 off its Microdose GLP-1 program, a free one-week trial, and …
Nestle is using artificial intelligence and nutritional science to develop products for the millions of Americans taking GLP-1 weight-loss drugs such as Ozempic and Wegovy, aiming to turn the rise of …
The US adult obesity rate fell to 36.4 percent in 2026, down from a peak of 39.9 percent in 2022, according to a Gallup report, while the share of adults taking GLP-1 drugs for weight loss rose from 3…
The August issue of The Highlight features a cover story by Dylan Scott on the persistent stigma surrounding GLP-1 drugs like Ozempic, Wegovy, and Mounjaro, despite their popularity. Other articles in…
Stanford Medicine researchers have discovered a naturally occurring molecule, BRP, that suppresses appetite and reduces body weight like Ozempic but without nausea, constipation, or significant muscle…
Researchers at Stanford Medicine used artificial intelligence to identify BRP (BRINP2-related peptide), a naturally occurring molecule that reduced food intake and body weight in mice and pigs without…
Technology is increasingly being used to modify human biology and cognition rather than the external world, as seen in AI tools that reduce cognitive effort and GLP-1 drugs that suppress desire. This …
Rich consumers taking GLP-1 weight-loss drugs are buying new wardrobes and dining on smaller, fancier dishes, providing a boost to the luxury sector amid a slight downturn. Bain & Co's Luxury Monitor …
Cyber extortion group FulcrumSec claimed on Tuesday to have stolen over a terabyte of data from pharmaceutical giant Novo Nordisk and attempted a $25 million extortion. The group said it is now explor…
GLP-1 drug use peaks in middle age, with 22% of adults aged 50-64 taking them, then drops sharply to 9% at age 65 due to Medicare's ban on covering weight-loss medications. The overall adult usage rat…
Researchers at the University of Pennsylvania analyzed over 400,000 Reddit posts from nearly 70,000 users and found that patients taking GLP-1 weight-loss drugs like Ozempic frequently reported unexpe…